News
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results